Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 32, 2013, Pages

  Muñoz, Denise P ^a   Lee, Elbert L ^a   Takayama, Sachiko ^a   Coppé, Jean Philippe ^b   Heo, Seok Jin ^a   Boffelli, Dario ^a   Di Noia, Javier M ^c,d   Martin, David I K ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACTIVATION INDUCED CYTIDINE DEAMINASE; DNA METHYLTRANSFERASE 1; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL INVASION; CELL STRUCTURE; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; AZACITIDINE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CPG ISLANDS; CYTIDINE DEAMINASE; DNA METHYLATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION TEST; HEK293 CELLS; HUMANS; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881403918     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301021110     Document Type: Article

References (84)

1. Di Noia JM, Neuberger MS (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76:1-22.
2. Chaudhuri J, et al. (2007) Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol 94:157-214.
3. Conticello SG (2008) The AID/APOBEC family of nucleic acid mutators. Genome Biol 9(6):229.
4. Meyers G, et al. (2011) Activation-induced cytidine deaminase (AID) is required for Bcell tolerance in humans. Proc Natl Acad Sci USA 108(28):11554-11559.
5. Kuraoka M, et al. (2011) Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci USA 108(28):11560-11565.
6. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK (2004) Activationinduced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J Biol Chem 279(50): 52353-52360.
7. Schreck S, et al. (2006) Activation-induced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J Pathol 210(1):26-31.
8. Bhutani N, et al. (2010) Reprogramming towards pluripotency requires AIDdependent DNA demethylation. Nature 463(7284):1042-1047.
9. Popp C, et al. (2010) Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463(7284):1101-1105.
10. Rai K, et al. (2008) DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135(7):1201-1212.
11. Dedeoglu F, Horwitz B, Chaudhuri J, Alt FW, Geha RS (2004) Induction of activationinduced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int Immunol 16(3):395-404.
12. Park SR, et al. (2009) HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat Immunol 10(5):540-550.
13. Gonda H, et al. (2003) The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 198(9):1427-1437.
14. Komori J, et al. (2008) Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 47(3):888-896.
15. Endo Y, et al. (2008) Activation-induced cytidine deaminase links between inflammationandthedevelopmentof colitis-associatedcolorectal cancers.Gastroenterology 135(3):889-898.
16. Endo Y, et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 26(38):5587-5595.
17. Kou T, et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer 120(3):469-476.
18. Matsumoto Y, et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13(4):470-476.
19. Gupta PB, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138(4):645-659.
20. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 66(8):3996-4000.
21. Pauklin S, Sernández IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK (2009) Estrogen directly activates AID transcription and function. J Exp Med 206(1):99-111.
22. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010-1022.
23. Riggs AD (1975) X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 14(1):9-25.
24. Reik W, Collick A, Norris ML, Barton SC, Surani MA (1987) Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature 328(6127):248-251.
25. Bourc'his D, Bestor TH (2004) Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431(7004):96-99.
26. Ooi SK, O'Donnell AH, Bestor TH (2009) Mammalian cytosine methylation at a glance. J Cell Sci 122(Pt 16):2787-2791.
27. Suzuki MM, Bird A (2008) DNA methylation landscapes: Provocative insights from epigenomics. Nat Rev Genet 9(6):465-476.
28. Bhutani N, Burns DM, Blau HM (2011) DNA demethylation dynamics. Cell 146(6): 866-872.
29. Franchini DM, Schmitz KM, Petersen-Mahrt SK (2012) 5-Methylcytosine DNA demethylation: More than losing a methyl group. Annu Rev Genet 46:419-441.
30. Cortellino S, et al. (2011) Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146(1):67-79.
31. Bhutani N, et al. (2013) A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells. FASEB J 27(3):1107-1113.
32. Hugo H, et al. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213(2):374-383.
33. Tomaskovic-Crook E, Thompson EW, Thiery JP (2009) Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11(6):213.
34. Lindley LE, Briegel KJ (2010) Molecular characterization of TGFbeta-induced epithelialmesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun 399(4):659-664.
35. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890.
36. Peinado H, Portillo F, Cano A (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48(5-6):365-375.
37. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelialmesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 119(6):1438-1449.
38. Blick T, et al. (2010) Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 15(2):235-252.
39. Mani SA, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704-715.
40. Morel AP, et al. (2008) Generation of breast cancer stem cells through epithelialmesenchymal transition. PLoS ONE 3(8):e2888.
41. Kurrey NK, et al. (2009) Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27(9):2059-2068.
42. Coppé JP, et al. (2008) Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6(12):2853-2868.
43. Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5):576-590.
44. Blick T, et al. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25(6):629-642.
45. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30(3):256-268.
46. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE (1995) p53-dependent and p53- independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128(6):1185-1196.
47. Debnath J, Brugge JS (2005) Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev Cancer 5(9):675-688.
48. Imbalzano KM, Tatarkova I, Imbalzano AN, Nickerson JA (2009) Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in threedimensional basement membrane culture. Cancer Cell Int 9:7.
49. Thompson EW, et al. (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150(3):534-544.
50. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147(3):631-644.
51. Kamitani S, et al. (2011) Simultaneous stimulation with TGF-β1 and TNF-α induces epithelial mesenchymal transition in bronchial epithelial cells. Int Arch Allergy Immunol 155(2):119-128.
52. Câmara J, Jarai G (2010) Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNFalpha. Fibrogenesis Tissue Repair 3(1):2.
53. Slattery C, McMorrow T, Ryan MP (2006) Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett 580(17):4021-4030.
54. Heldin CH, Landström M, Moustakas A (2009) Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21(2):166-176.
55. Thuault S, et al. (2008) HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 283(48):33437-33446.
56. Thuault S, et al. (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174(2):175-183.
57. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452(7184): 187-193.
58. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8(3):221-233.
59. Feng S, et al. (2011) Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS ONE 6(8):e20599.
60. Wiseman BS, et al. (2003) Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162(6): 1123-1133.
61. Creighton CJ, Chang JC, Rosen JM (2010) Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15(2):253-260.
62. Lin CY, et al. (2011) Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci 102(4):815-827.
63. Patenaude AM, et al. (2009) Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 16(5):517-527.
64. Wu X, Darce JR, Chang SK, Nowakowski GS, Jelinek DF (2008) Alternative splicing regulates activation-induced cytidine deaminase (AID): Implications for suppression of AID mutagenic activity in normal and malignant B cells. Blood 112 (12):4675-4682.
65. Burk U, et al. (2008) A reciprocal repression between ZEB1 and members of the miR- 200 family promotes EMT and invasion in cancer cells. EMBO Rep 9(6):582-589.
66. Bhat-Nakshatri P, et al. (2010) SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer 10:411.
67. Thillainadesan G, et al. (2012) TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 46(5):636-649.
68. Pavri R, et al. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143(1):122-133.
69. Willmann KL, et al. (2012) A role for the RNA pol II-associated PAF complex in AIDinduced immune diversification. J Exp Med 209(11):2099-2111.
70. Cortázar D, et al. (2011) Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 470(7334):419-423.
71. Li YQ, Zhou PZ, Zheng XD, Walsh CP, Xu GL (2007) Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair. Nucleic Acids Res 35(2):390-400.
72. Tini M, et al. (2002) Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol Cell 9(2):265-277.
73. Chen D, et al. (2003) T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha. J Biol Chem 278(40):38586-38592.
74. Um S, et al. (1998) Retinoic acid receptors interact physically and functionally with the T:G mismatch-specific thymine-DNA glycosylase. J Biol Chem 273(33):20728-20736.
75. Orthwein A, Di Noia JM (2012) Activation induced deaminase: How much and where? Semin Immunol 24(4):246-254.
76. Guo JU, Su Y, Zhong C, Ming GL, Song H (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145(3):423-434.
77. MacDuff DA, Demorest ZL, Harris RS (2009) AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res 37(6):1854-1867.
78. Campeau E, et al. (2009) A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS ONE 4(8):e6529.
79. Muñoz DP, Kawahara M, Yannone SM (2013) An autonomous chromatin/DNA-PK mechanism for localized DNA damage signaling in mammalian cells. Nucleic Acids Res 41 (5):2894-2906.
80. Spandidos A, Wang X, Wang H, Seed B (2010) PrimerBank: A resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38(Database issue):D792-D799.
81. Dumont N, et al. (2008) Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 105(39):14867-14872.
82. Li LC, Dahiya R (2002) MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18(11):1427-1431.
83. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med 17(8):857-872.
84. Kumar R, et al. (2013) AID stabilizes stem-cell phenotype by removing epigenetic memory of pluripotency genes. Nature, 10.1038/nature12299.